Iguana Healthcare Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Iguana Healthcare Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-110,000	Closed	-$2.97M	–	103
2015 Q4	$2.97M	Sell	110,000 -15,000	-12%	-$409K	0.98%	28
2015 Q3	$3.47M	Buy	+125,000	New	+$3.94M	1.37%	24
2014 Q4	–	Sell	-180,000	Closed	-$1.73M	–	82
2014 Q3	$1.73M	Buy	180,000 +80,000	+80%	+$796K	0.92%	42
2014 Q2	$918K	Sell	100,000 -12,500	-11%	-$114K	0.43%	57
2014 Q1	$1.22M	Buy	+112,500	New	+$1.1M	0.56%	50

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iguana Healthcare Management's LJPC Position: Q1 2016 in Review

Iguana Healthcare Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2016, closing a stake of 110,000 shares — an estimated $2.97M sold.

Iguana Healthcare Management first reported a position in LJPC in Q1 2014 and held it in 5 quarters. The position peaked at $3.47M in Q3 2015. 70 funds tracked by Wall St. Rank hold LJPC as of Q1 2016.

Iguana Healthcare Management reported no remaining La Jolla Pharmaceutical Company position as of Q1 2016 after selling out during the quarter.
Iguana Healthcare Management sold 110,000 La Jolla Pharmaceutical Company shares in Q1 2016, an estimated $2.97M.
Iguana Healthcare Management first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 5 quarters.
Iguana Healthcare Management's La Jolla Pharmaceutical Company position peaked at $3.47M in Q3 2015.
70 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2016.

Based on Iguana Healthcare Management's 13F filing for Q1 2016, filed 17 May 2016.